3-(2-HYDROXYHEXAFLUORO-2-PROPYL)-5-(2H-HEXAFLUORO-2-PROPYL)PYRIDINE AND 3,5-DI-(2-HYDROXYHEXAFLUORO-2-PROPYL)PYRIDINE

DOI: 10.1007/BF00954634

Source and publish data:

Bulletin of the Academy of Sciences of the USSR Division of Chemical Science p. 1744 (1986)

Update date:2022-09-26

Topics:

Authors:

Sviridov, V. D.

Chkanikov, N. D.

Kolomiets, A. F.

Fokin, A. V.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1007/BF00954634

Full text of DOI:10.1007/BF00954634

Products guided by the article

Product name:2,2’-(pyridine-3,5-diyl)bis(1,1,1,3,3,3-hexafluoropropan-2-ol)

Cas No:108440-28-4

R&D Labs maybe for 108440-28-4

Zhongshan Haihong Medicine Co., Ltd.

Contact:86-0760-86925778 （0）18824993998

Address:A7 building,lianyuan road Torch Hi-tech Industrial Development Zone
Tianjin Tensing Fine Chemical Research Develop Centre

Contact:86-022-23718576,13032267585

Address:2-2-201,13 Guiyuan road,Huayuan Industry district,Tianjin,china
HANGZHOU ZHONGCHANG SCIENTIFIC CO.,LTD

Contact:+86-571-88932183

Address:Hangzhou
SuZhou Bichal Biological Technology CO.,LTD

Contact:+86-512-68051130

Address:NO.32 huoju road HI-TECH Industrial development zone SuZhou China
nanjing suru chemical co.ltd

Contact:+86-025-52406782

Address:8 Taizishan Rd., Yanjiang Industrial Development Area, Nanjing, Jiangsu, China.

Relevant to this article

Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels

Doi:10.1016/j.bmc.2014.10.020
(2014)
Accelerating Electrochemical Reactions in a Voltage-Controlled Interfacial Microreactor

Doi:10.1002/anie.202007736
(2020)
NEW REACTION OF MALONONITRILE AND ARYLIDENE- AND 1-ARYLETHYLIDENEMALONONITRILES

Doi:10.1007/BF00478146
(1986)
Intramolecularly two-centered cooperation catalysis for the synthesis of cyclic carbonates from CO₂ and epoxides

Doi:10.1016/j.tetlet.2008.09.035
(2008)
Structure-Based Design of Selective, Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors

Doi:10.1021/acsmedchemlett.9b00365
(2019)
A Michael Addition-Induced Favorskii Rearrangement

Doi:10.1246/bcsj.60.836
(1987)

Article Doi